Recent content by KJS

If you have read an IPO prospectus they are usually overly cautious on risk indicators. They have to be to avoid litigation to investors. Kind of like side effect indicators to most medicines.

I would imagine they tested cochlea implant patients first since the first phase as a safety test. I assume they figured that a person's ear was completely damaged already so they want to make sure the drug would not cause more issues. The next phase will have patients that have stable SSNHL...

How do they determine if it is hair cell loss or nerve damage?

When he says commands a premium, he may be referring to valuation of the company, not necessarily premium of treatment. My guess is though yes if successful they will get a premium for the treatment. Two times Hearing Aids might be the floor. If the treatment is too expensive and insurance...

Luminox...Mine started in 7/9/2018....Been trying deal with it. I am in North Texas. Hang in there.